1-3 of 3
Tim Grob
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Double mutant DNMT3A AML: a unique subtype experiencing increased DNA damage and poor prognosis

Emma L. Boertjes, Sanne Massaar, Annelieke Zeilemaker, Jolinda Konijnenburg, Melissa Rijken, François G. Kavelaars, Tim Grob, Jurjen Versluis, Bob Löwenberg, Peter J.M. Valk, Mathijs Arnoud Sanders
Journal: Blood Advances
Blood Adv bloodadvances.2024014698.
https://doi.org/10.1182/bloodadvances.2024014698
Published: 2024
Includes: Supplemental data
Journal Articles

Advantages of a genomic DNA-based NGS assay for detection of mutant NPM1 measurable residual disease in AML

Christian M Vonk, Tim Grob, Melissa Rijken, François G. Kavelaars, Jolinda Konijnenburg, Gert J Ossenkoppele, Markus G. Manz, Yngvar Floisand, Bob Löwenberg, Peter J.M. Valk
Journal: Blood Advances
Blood Adv bloodadvances.2024014490.
https://doi.org/10.1182/bloodadvances.2024014490
Published: 2024
Includes: Supplemental data
Journal Articles

Panobinostat and decitabine prior to donor lymphocyte infusion in allogeneic stem cell transplantation

Clinical Trials & Observations
Burak Kalin, Yvette van Norden, Michel van Gelder, Dimitri Breems, Johan Maertens, Mojca Jongen-Lavrencic, Annoek E. C. Broers, Eric Braakman, Tim Grob, Wendelien Zeijlemaker, Gert J. Ossenkoppele, Ellen Meijer, Jan J. Cornelissen
Journal: Blood Advances
Blood Adv (2020) 4 (18): 4430–4437.
https://doi.org/10.1182/bloodadvances.2020002074
Published: 2020
Includes: Supplemental data